J&J Completes Codman Sale to Integra for more than $1B

Johnson & Johnson (NYSE:JNJ) completes the sale of its Codman Neurosurgery unit to Integra LifeSciences Holding (NASDAQ:IART) for $1.045B.

Previously: Integra to buy J&J's Codman Neurosurgery unit for $1.045B(Feb. 15)

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.